Aller au contenu principal
Profil bibliographique

Misha Shamashkin

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

3Publications signalées
7Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Virus-based gene therapy researchCAR-T cell therapy researchViral Infectious Diseases and Gene Expression in Insects

Les publications récentes

2023 conference-abstract OpenAlex

Feasibility of Extracorporeal Delivery of Fusosomes to Generate CAR T Cells In Vivo

Jesse Green, Andrew Tucker, Aesha Vakil, Matt Scott-Skandera et autres

Fusosomes are viral vectors pseudotyped with modified paramyxovirus envelopes targeting specific cell types. A CD8-targeted fusosome delivering a CD19CAR transgene has the potential to provide an off-the-shelf therapeutic approach to generate in vivo CD19-directed chimeric antigen receptor (CAR) T cells in patients. …

us (code pays fourni par la source)

1 citation Blood
2023 conference-abstract OpenAlex

Abstract LB311: Increased potency of CD8-targeted fusosomes enhances CAR gene delivery to resting primary T cells

Jesse Green, Brian Granger, Ouwen Liang, Jesus Moreno et autres

Abstract Introduction: Fusosomes are viral vectors pseudotyped with modified paramyxovirus envelopes targeting specific cell types. A CD8-targeted fusosome delivering CD19CAR transgene has the potential to provide an off-the-shelf therapeutic approach to generate CD19-directed chimeric antigen receptor (CAR) T cells in patients after …

us (code pays fourni par la source)

0 citations Cancer Research
2021 conference-abstract OpenAlex

In Vivo Delivery of a CD20 CAR Using a CD8-Targeted Fusosome in Southern Pig-Tail Macaques (M. nemestrina) Results in B Cell Depletion

Justine J. Cunningham, Sundeep Chandra, Akinola Olumide Emmanuel, Allyse Mazzarelli et autres

Abstract Introduction: Ex vivo manufactured chimeric antigen receptor (CAR) T cell therapies are highly effective for treating B cell malignancies. However, the complexity, cost and time required to manufacture CAR T cells limits access. To overcome conventional ex vivo CAR T limitations, …

us (code pays fourni par la source)

6 citations Blood

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.